Adaptive Biotechnologies Corp (ADPT)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Chad Robins
Employees:
860
1551 EASTLAKE AVENUE EAST SUITE 200, SEATTLE, WA 98102
206-659-0067

Adaptive Biotechnologies Corporation develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signals. It serves the life sciences research, clinical diagnostics, and drug discovery applications.

Data derived from most recent annual or quarterly report
Market Cap 924.482 Million Shares Outstanding142.228 Million Avg 30-day Volume 1.147 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.4
Price to Revenue7.2128 Debt to Equity0.0 EBITDA-210.389 Million
Price to Book Value2.2221 Operating Margin-146.2264 Enterprise Value701.067 Million
Current Ratio3.935 EPS Growth-0.331 Quick Ratio3.655
1 Yr BETA 2.2072 52-week High/Low 39.03 / 5.96 Profit Margin-145.4405
Operating Cash Flow Growth-14.4302 Altman Z-Score0.6792 Free Cash Flow to Firm -227.327 Million
Earnings Report2022-11-02

Are you looking for this stock instead?

View SEC Filings from ADPT instead.

View recent insider trading info

Funds Holding ADPT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ADPT

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-09-12:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-03:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-14:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-05-04:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-25:
    Item 8.01: Other Events
  • 8-K: filed on 2022-03-11:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-02-15:
    Item 2.02: Results of Operations and Financial Condition
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-01-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-08-04:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-06-14:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • Prospectus

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    17.5 Thousand total shares from 1 transactions

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    SOOD NITIN CHIEF COMMERCIAL OFFICER, MRD

    • Officer
    145,571 2022-08-05 2

    ADAMS R MARK CHIEF OPERATING OFFICER

    • Officer
    119,768 2022-07-07 5

    PETERSON TYCHO CHIEF FINANCIAL OFFICER

    • Officer
    0 2022-06-01 2

    LO FRANCIS CHIEF PEOPLE OFFICER

    • Officer
    92,088 2022-03-08 2

    BALDO LANCE CHIEF MEDICAL OFFICER

    • Officer
    17,171 2022-03-08 2

    TAYLOR STACY L SVP AND GENERAL COUNSEL

    • Officer
    72,859 2022-03-08 3

    ROBINS CHAD M CEO AND CHAIRMAN

    • Officer
    • Director
    8,059,572 2022-03-07 2

    PISKEL KYLE PRINCIPAL ACCOUNTING OFFICER

    • Officer
    198,515 2022-03-04 3

    RUBINSTEIN JULIE PRESIDENT

    • Officer
    920,983 2022-03-04 1

    ROBINS HARLAN S CHIEF SCIENTIFIC OFFICER

    • Officer
    1,246,229 2022-03-04 4

    BENZENO SHARON CHIEF BUSINESS DEVELOPMENT OFF

    • Officer
    413,793 2022-03-04 1

    GRIFFIN MICHELLE RENEE

    • Director
    24,915 2022-01-26 1

    NEUPERT PETER M

    • Director
    24,915 2022-01-26 1

    HERSHBERG ROBERT

    • Director
    24,915 2022-01-26 1

    TRIGG LESLIE

    • Director
    27,854 2022-01-26 1

    CONROY KEVIN T

    • Director
    24,915 2022-01-26 1

    PELLINI MICHAEL J

    • Director
    24,915 2022-01-26 1

    OWEN KATEY EINTERZ

    • Director
    27,854 2022-01-26 1

    COHEN CHAD M CHIEF FINANCIAL OFFICER

    • Officer
    101,604 2021-12-22 3

    PALANIAPPAN JYOTI SVP, DIAGNOSTICS, T-DETECT

    • Officer
    113,551 2021-07-19 0

    THORSEN HENNING SVP, COMMERCIAL OPERATIONS

    • Officer
    101,714 2021-05-17 0

    GOEL DAVID E.

    MATRIX CAPITAL MANAGEMENT COMPANY, LP

    • Director
    • SEE REMARKSSEE REMARKS
    12,310,594 2021-03-08 0

    BOBULSKY SUSAN SVP, DIAGNOSTICS, CLONOSEQ

    • Officer
    32,052 2021-03-04 0

    GOEL DAVID E.

    • Director
    1,504 2021-02-15 0

    DOBMEIER ERIC

    • Director
    1,504 2021-02-14 0

    HILL NANCY LOUISE EVP, OPERATIONS & PROGRAM MANA

    • Officer
    23,200 2021-01-19 0

    VIKING GLOBAL INVESTORS LP

    VIKING GLOBAL PERFORMANCE LLC

    VIKING GLOBAL EQUITIES II LP

    VIKING GLOBAL EQUITIES MASTER LTD.

    VIKING LONG FUND GP LLC

    VIKING LONG FUND MASTER LTD.

    HALVORSEN OLE ANDREAS

    OTT DAVID C.

    SHABET ROSE SHARON

    • 10% Owner
    29,993,708 2020-12-14 0

    SANG CHARLES SVP, EXTERNAL AFFAIRS

    • Officer
    0 2020-12-11 0

    VIKING GLOBAL INVESTORS LP

    VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP

    VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC

    VIKING GLOBAL OPPORTUNITIES GP LLC

    HALVORSEN OLE ANDREAS

    OTT DAVID C.

    SHABET ROSE SHARON

    • 10% Owner
    30,993,708 2020-11-11 0

    VIKING GLOBAL PERFORMANCE LLC

    VIKING GLOBAL EQUITIES II LP

    VIKING GLOBAL EQUITIES MASTER LTD.

    VIKING LONG FUND GP LLC

    VIKING LONG FUND MASTER LTD.

    HALVORSEN OLE ANDREAS

    OTT DAVID C.

    SHABET ROSE SHARON

    • 10% Owner
    30,993,708 2020-11-11 0

    ZOLTNERS ANDRIS A

    • Director
    0 2020-02-13 0

    VIKING GLOBAL PERFORMANCE LLC

    VIKING GLOBAL EQUITIES MASTER LTD.

    VIKING LONG FUND GP LLC

    VIKING LONG FUND MASTER LTD.

    HALVORSEN OLE ANDREAS

    OTT DAVID C.

    SHABET ROSE SHARON

    • 10% Owner
    38,406,607 2019-07-01 0

    SPH GROUP HOLDINGS LLC

    STEEL PARTNERS HOLDINGS L.P.

    STEEL PARTNERS LLC

    LICHTENSTEIN WARREN G PRESIDENT OF SUBSIDIARY

    SPH GROUP LLC

    • Officer
    • Director
    • 10% Owner
    41,031,674 2011-09-27 0

    STEEL PARTNERS II LP

    STEEL PARTNERS LLC

    LICHTENSTEIN WARREN G PRESIDENT OF SUBSIDIARY

    STEEL PARTNERS HOLDINGS L.P.

    • Officer
    • Director
    • 10% Owner
    37,094,472 2011-05-27 0

    STEEL PARTNERS II LP

    STEEL PARTNERS LLC

    LICHTENSTEIN WARREN G

    STEEL PARTNERS HOLDINGS L.P.

    STEEL PARTNERS II GP LLC

    • 10% Owner
    23,469,843 2009-12-16 0

    DOTZ MARY CHIEF FINANCIAL OFFICER

    • Officer
    85,000 2009-02-18 0

    SUNDARESH SUBRAMANIAN PRESIDENT & CEO

    • Officer
    333,518 2009-02-18 0

    STEEL PARTNERS II LP

    STEEL PARTNERS LLC

    LICHTENSTEIN WARREN G

    STEEL PARTNERS II GP LLC

    STEEL PARTNERS II MASTER FUND L.P.

    • 10% Owner
    23,171,338 2008-11-17 0

    CHEN TED VP MARKETING

    • Officer
    0 2007-03-27 0

    GOYAL MANOJ VP GLOBAL PRODUCT DEVELOPMENT

    • Officer
    18,000 2007-03-27 0

    TERLIZZI STEPHEN VP & GM OF SSG

    • Officer
    0 2007-03-27 0

    JOHNSON RUSSELL VP WORLD WIDE SALES

    • Officer
    21,066 2007-03-27 0

    STEEL PARTNERS II LP

    STEEL PARTNERS LLC

    LICHTENSTEIN WARREN G

    • 10% Owner
    12,717,587 2007-03-09 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    SOOD NITIN - Officer CHIEF COMMERCIAL OFFICER, MRD

    2022-08-05 20:49:34 -0400 2022-08-05 S 17,540 $10.98 d 145,571 direct -4.1061 8.3832 -35.2438 8.3832 6 -35.2438 31

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    ADAPTIVE BIOTECHNOLOGIES ADPT 2022-09-23 22:15:03 UTC 2.6402 0.4298 1700000
    ADAPTIVE BIOTECHNOLOGIES ADPT 2022-09-23 21:45:03 UTC 2.6402 0.4298 1700000
    ADAPTIVE BIOTECHNOLOGIES ADPT 2022-09-23 21:15:03 UTC 2.6402 0.4298 1700000
    ADAPTIVE BIOTECHNOLOGIES ADPT 2022-09-23 20:45:03 UTC 2.6402 0.4298 1700000
    ADAPTIVE BIOTECHNOLOGIES ADPT 2022-09-23 20:15:06 UTC 2.6402 0.4298 1700000
    ADAPTIVE BIOTECHNOLOGIES ADPT 2022-09-23 19:45:03 UTC 2.6402 0.4298 1700000
    ADAPTIVE BIOTECHNOLOGIES ADPT 2022-09-23 19:15:03 UTC 2.6402 0.4298 1700000
    ADAPTIVE BIOTECHNOLOGIES ADPT 2022-09-23 18:45:03 UTC 2.6402 0.4298 1700000
    ADAPTIVE BIOTECHNOLOGIES ADPT 2022-09-23 18:15:04 UTC 2.6402 0.4298 1700000
    ADAPTIVE BIOTECHNOLOGIES ADPT 2022-09-23 17:45:04 UTC 2.6402 0.4298 1700000
    ADAPTIVE BIOTECHNOLOGIES ADPT 2022-09-23 17:15:04 UTC 2.6402 0.4298 1700000
    ADAPTIVE BIOTECHNOLOGIES ADPT 2022-09-23 16:45:03 UTC 2.6402 0.4298 1700000
    ADAPTIVE BIOTECHNOLOGIES ADPT 2022-09-23 16:15:03 UTC 2.6402 0.4298 1700000
    ADAPTIVE BIOTECHNOLOGIES ADPT 2022-09-23 15:45:03 UTC 2.6402 0.4298 1700000
    ADAPTIVE BIOTECHNOLOGIES ADPT 2022-09-23 15:15:03 UTC 2.6402 0.4298 1700000
    ADAPTIVE BIOTECHNOLOGIES ADPT 2022-09-23 14:45:03 UTC 1.8902 0.4298 1700000
    ADAPTIVE BIOTECHNOLOGIES ADPT 2022-09-23 14:15:03 UTC 1.8902 0.4298 1700000
    ADAPTIVE BIOTECHNOLOGIES ADPT 2022-09-23 13:45:03 UTC 1.8902 0.4298 1700000
    ADAPTIVE BIOTECHNOLOGIES ADPT 2022-09-23 13:15:03 UTC 1.8902 0.4298 1700000
    ADAPTIVE BIOTECHNOLOGIES ADPT 2022-09-23 12:45:03 UTC 1.8902 0.4298 1700000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Advisors Series Trust- Pzena Long/Short Value Fund ADPT -3381.0 shares, $-130844.7 2020-05-31 N-PORT
    FundVantage Trust- Gotham Enhanced Index Plus Fund ADPT -28.0 shares, $-777.84 2020-03-31 N-PORT
    FundVantage Trust- Gotham Master Neutral Fund ADPT -62.0 shares, $-3015.06 2020-09-30 N-PORT
    FundVantage Trust- Gotham Index Plus All-Cap Fund ADPT -89.0 shares, $-2472.42 2020-03-31 N-PORT
    JNL Series Trust- JNL/AQR Large Cap Relaxed Constraint Equity Fund ADPT -5653.0 shares, $-227589.78 2021-03-31 N-PORT
    Nuveen Investment Trust- Nuveen Equity Market Neutral Fund ADPT -5300.0 shares, $-200393.0 2021-05-31 N-PORT
    Prudential Investment Portfolios 12- PGIM QMA Large-Cap Core Equity Plus Fund ADPT -1900.0 shares, $-77634.0 2021-06-30 N-PORT
    SCHWAB CAPITAL TRUST- Schwab Hedged Equity Fund ADPT -3876.0 shares, $-142094.16 2021-07-31 N-PORT
    Prudential Investment Portfolios 12- PGIM QMA Long-Short Equity Fund ADPT -2900.0 shares, $-98571.0 2021-09-30 N-PORT
    Advanced Series Trust- AST QMA U.S. Equity Alpha Portfolio ADPT -36600.0 shares, $-1244034.0 2021-09-30 N-PORT
    Trust for Professional Managers- Convergence Long/Short Equity Fund ADPT -1061.0 shares, $-27681.49 2021-11-30 N-PORT
    Trust for Professional Managers- Convergence Long/Short Equity ETF ADPT -1708.0 shares, $-13356.56 2022-05-31 N-PORT
    Series Portfolios Trust- Weiss Alternative Multi-Strategy Fund ADPT -781.0 shares, $-6443.25 2022-04-30 N-PORT
    VANGUARD TRUSTEES' EQUITY FUND- VANGUARD ALTERNATIVE STRATEGIES FUND ADPT -8125.0 shares, $-67031.25 2022-04-30 N-PORT
    Weiss Strategic Interval Fund- Weiss Strategic Interval Fund ADPT -7020.0 shares, $-56791.8 2022-06-30 N-PORT
    FundVantage Trust- Gotham Hedged Plus Fund ADPT -179.0 shares, $-1448.11 2022-06-30 N-PORT
    AQR Funds- AQR Alternative Risk Premia Fund ADPT -12417.0 shares, $-100453.53 2022-06-30 N-PORT

    Elevate your investments